Abstract:3C-like protease is an extremely important protease involved in the multiplicative process of coronaviruses, including the deadly Middle East respiratory syndrome coronavirus (MERS-CoV). 3C-like protease has become a hot research topic in the field of coronavirology. For the first time, a set of ligand- and receptor based three-dimensional quantitative structure-activity relationships (3D-QSAR) models were carried out via comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) to explore the structure-activity correlation of 43 peptidomimetic inhibitors of the 3C-like protease of the bat coronavirus HKU4 (HKU4-CoV), which belongs to the same 2c lineage as MERS-CoV and shows high sequence similarity with MERS-CoV. Based on the ligand-based alignment, an optimal CoMSIA model (yielded by steric, electrostatic, H-bond donor and H-bond acceptor fields) was obtained with good predictive power of Q(2) = 0.522, = 0.996 and R-pre(2) = 0.904 (Q2: cross-validated correlation coefficient, R-pre(2): non-cross-validated correlation coefficient, R-pre(2): predicted correlation coefficient for the test set of compounds). Molecular docking and molecular dynamics simulations were performed according to this model to further determine the interaction mechanism between ligands and the receptor. The experimental results show: (1) based on the optimal CoMSIA model, the 3D contour maps vividly illustrate that the molecular biological activity is influenced by the steric, electrostatic, H-bond donor and H-bond acceptor interactions of molecular groups. (2) Based on the docking analysis, hydrophobicity, crystal water, His166 and Glu169 have important roles in the ligands and receptor binding process. (3) Molecular dynamics (MD) simulations were carried out for further verification of the reliability of the docking model, and provide two new key residues, Ser24 and GIn192, which have two strong hydrogen bonds with the ligands. Some new compounds were obtained based on the modeling that are potential peptidomimetic inhibitors of 3C-like protease. These results help establish the binding mechanism between 3C-like protease and peptidomimetic inhibitors, and provide a valuable reference for future anti-MERS-CoV drug design.

Pharmacophore Model and 3D-QSAR Study of Two Kinds of HCVNS3 Serine Protease Inhibitors

3D-QSAR and Molecular Docking Studies on Designing Inhibitors of the Hepatitis C Virus NS5B Polymerase

Insight into the structural requirements of narlaprevir-type inhibitors of NS3/NS4A protease based on HQSAR and molecular field analyses.

Common Pharmacophore Model and 3D-QSAR Analysis of Two Different Tyrphostin Families

Insight into the structural requirements of benzothiadiazine scaffold-based derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics

3D-QSAR Analysis of Sialyltransferase Inhibitors

The 3D-QSAR and Pharmacophore Studies of Pyrimidine Derivatives As HCV Replication (replicase) Inhibitor

Combined 3D-QSAR, Molecular Docking and Molecular Dynamics Study on the Benzimidazole Inhibitors Targeting HCV NS5B Polymerase

Computational Study on the Inhibitor Binding Mode and Allosteric Regulation Mechanism in Hepatitis C Virus Ns3/4a Protein

Screening Novel HIV-1 Protease Inhibitors Based on the Substrate Envelope Hypothesis

3D-QSAR Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulation Toward Identifying Lead Compounds for NS2B-NS3 Protease Inhibitors.

Pharmacophore Model Analysis Of Novel Tyrphostins

Pharmacophore Model Construction of β-Secretase Inhibitors

The index of ideality of correlation: QSAR studies of hepatitis C virus NS3/4A protease inhibitors using SMILES descriptors

3D-QSAR Study for Inhibitors of Cyclin-Dependent Kinase 4

Studies of Benzothiadiazine Derivatives As Hepatitis C Virus NS5B Polymerase Inhibitors Using 3D-QSAR, Molecular Docking and Molecular Dynamics.

Pharmacophore model construction of beta-secretase inhibitors

3D-QSAR Study and Design of 4-Hydroxyamino Α-Pyranone Carboxamide Analogues As Potential Anti-Hcv Agents

3D-QSAR Modeling, Surflex Docking and Reverse Docking Studies of Diketo-Acid Derivatives as Potent Integrase/Rnase H Inhibitors

Activity prediction of hepatitis C virus NS5B polymerase inhibitors of pyridazinone derivatives

Qsar, Molecular Docking and Molecular Dynamics of 3C-Like Protease Inhibitors